FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct.

Today's Daily Dose brings you news about AcelRx Pharma's regulatory catalyst in October; positive acne trial results of Foamix; Galapagos' rheumatoid arthritis trial results; trading halt in OPKO and Viveve Medical's progress in stress urinary incontinence studies.

from RTT - Biotech https://ift.tt/2NDvWv4
via IFTTT